PTH (1-84) Human

Parathyroid Hormone (1-84) Human Recombinant
Cat. No.
BT19490
Source
Escherichia Coli.
Synonyms
Parathyrin, PTH, Parathormone.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity

Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.

Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Parathyroid Hormone 1-84 (full length) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 84 amino acids, having an MW of ~9.4kDa.
The PTH is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Parathyroid hormone (PTH), also known as parathormone, is an 84-amino acid polypeptide secreted by the parathyroid glands. It functions to elevate calcium levels in the bloodstream, in contrast to calcitonin (produced by the thyroid gland's parafollicular cells) which lowers calcium concentration. PTH increases blood calcium levels by targeting parathyroid hormone receptors in three key areas: 1. **Bones:** PTH promotes calcium release from bone reserves. This process, called bone resorption, involves the breakdown of bone by osteoclasts, which are indirectly stimulated by PTH. Osteoclasts lack PTH receptors; instead, PTH binds to osteoblasts (bone-forming cells), prompting them to increase RANKL expression. RANKL binds to RANK receptors on osteoclast precursors, triggering their fusion into mature osteoclasts, thus enhancing bone resorption. 2. **Kidneys:** PTH enhances active calcium reabsorption in the distal tubules and thick ascending limb of the kidneys. 3. **Intestines:** PTH boosts intestinal calcium absorption by increasing vitamin D production and upregulating the enzyme responsible for converting vitamin D to its active form (1,25-dihydroxy vitamin D) through 1-alpha hydroxylation of 25-hydroxy vitamin D. Active vitamin D facilitates calcium absorption (as Ca2+ ions) in the intestine via calbindin. Recombinant Human full-length PTH 1-84 shows potential as an anti-osteoporotic agent. Its bone formation-stimulating properties increase bone turnover, stimulating osteoblasts and reducing both vertebral and non-vertebral fractures.
Description
Parathyroid Hormone 1-84 (full length) Human Recombinant, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 84 amino acids, with a molecular weight of approximately 9.4 kDa. The PTH is purified using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White Lyophilized (Freeze-Dried) Powder
Formulation
Lyophilized from a 0.2 μm filtered concentrated solution in phosphate-buffered saline (PBS) at pH 7.4.
Solubility
Reconstitute the lyophilized Parathormone in sterile 18 MΩ-cm H2O at a concentration of at least 100 μg/ml. Further dilutions can be made in other aqueous solutions.
Stability
Lyophilized Parathyrin remains stable at room temperature for 3 weeks but should be stored desiccated below -18°C. Upon reconstitution, store PTH at 4°C for 2-7 days. For long-term storage, freeze at -18°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid freeze-thaw cycles.
Purity
Greater than 95.0% as determined by: (a) Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analysis (b) Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) analysis
Biological Activity
The activity is determined by its capacity to induce cAMP accumulation in murine MC3T3E1 cells and is <50 ng/ml, corresponding to a specific activity exceeding 2.0 x 104 Units/mg.
Synonyms
Parathyrin, PTH, Parathormone.
Source
Escherichia Coli.
Amino Acid Sequence
SVSEIQLMHN LGKHLNSMER VEWLRKKLQD VHNFVALGAP LAPRDAGSQR PRKKEDNVLV ESHEKSLGEA DKADVNVLTK AKSQ.

Product Science Overview

Mechanism of Action

Recombinant human parathyroid hormone (rhPTH 1-84) binds to PTH-1 receptors in the bone and kidney, and indirectly affects calcium reabsorption in the intestines . It increases serum calcium levels by:

  • Enhancing renal tubular calcium reabsorption
  • Increasing intestinal calcium absorption
  • Promoting bone turnover
Clinical Applications

rhPTH 1-84 is primarily used as an adjunct to calcium and vitamin D therapy for the control of hypocalcemia in patients with hypoparathyroidism . Hypoparathyroidism is a rare endocrine disorder characterized by insufficient levels of PTH, leading to imbalances in calcium and phosphate levels . This condition can result from surgical removal or damage to the parathyroid glands, autoimmune disorders, genetic mutations, or other factors .

Efficacy and Safety

Clinical trials have demonstrated that rhPTH 1-84 is effective in maintaining serum calcium levels while reducing the need for oral calcium and active vitamin D supplementation . However, it carries a black box warning for the potential risk of osteosarcoma, a type of bone cancer . Common adverse reactions include hypocalcemia, hypercalcemia, and hypercalciuria .

Pharmacological Properties

rhPTH 1-84 is administered subcutaneously and has been shown to have a generally acceptable tolerability profile . It represents a significant advancement in the management of hypoparathyroidism, offering an effective regimen for patients who cannot be well-controlled on calcium and vitamin D supplementation alone .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.